Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointin

Innovent Biologics, Inc. and Eli Lilly and Co. (NYSE:LLY) on Tuesday entered into a distribution and

Innovent and Eli Lilly sign a China commercialization deal for Verzenios, expanding patient access w

If you sort all the top politicians with a portfolio of above $1 million using their annual gains, w

Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years by 7.2% on an annualized bas

Eli Lilly (LLY, Financials) is turning to Innovent Biologics to handle sales of Verzenio in mainland

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after recei

Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility a

A bipartisan group of United States lawmakers has opened national security investigations into wheth

Eli Lilly (LLY) is expanding its China oncology reach through a new commercialization agreement with

Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron

Eli Lilly is leveraging its exceptional cash flow to build an AI-native drug discovery and manufactu

Investors rushed to get in on SpaceX's IPO -- and benefit from the company's innovation and growth.

Innovent Biologics ​has entered ‌into an agreement that ​grants ​it sole commercialization ⁠rights f

SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent")

The latest trading day saw Eli Lilly (LLY) settling at $1, representing a +1.81% change from its pre

The U.S. ​Food and ‌Drug Administration has ​selected Eli ​Lilly and Regeneron , ⁠among ​seven compa

Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin

LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, ap

LLY hit a record high after a positive EU panel opinion for Jaypirca and expanded $50/month Medicare

Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average.

Why settle for puny yields when you can buy these monster dividend stocks?

Millions of older Americans in Medicare are about to gain access to obesity drugs through Medicare's

Eli Lilly saw its biggest gain of 7% in yesterday's trading session since early February, when it ju

The top stocks flourish buy points and relative strength. Two are defensive growth names.

Eli Lilly (LLY +7.51%) is benefiting from its blockbuster weight loss treatment.

Eli Lilly's leukemia drug is making progress toward regulatory approval in the EU. The healthcare le

Healthcare stocks outperformed the broader market on Friday, with Eli Lilly (LLY), Johnson and Johns

Eli Lilly and Co (NYSE:LLY) shares climbed nearly 6% on Friday after the European Medicines Agency's

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults w

The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, pr

The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, pr

Eli Lilly and Co (NYSE:LLY) shares climbed nearly 6% on Friday after the European Medicines Agency's

Leerink Partners analyst David Risinger maintains Eli Lilly (NYSE:LLY) with a Outperform and rais

ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concur

The Medicare GLP-1 Bridge program will be the first time eligible Medicare Part D patients will be a

A new Medicare pathway, the Medicare GLP-1 Bridge program, makes Lilly's obesity medicines – a daily

ProQR Therapeutics N.V. (NASDAQ:PRQR) ("ProQR"), a clinical-stage biotechnology company dedi

Nancy Pelosi Stock Tracker told investors to "keep an eye" on Eli Lilly and Nokia after Trum

Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel me

White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide throug

Coatue founder Philippe Laffont redefines the Mag 7 into a trillion-dollar "Mag 12," adding

Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medi

As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s

Eli Lilly (NYSE:LLY) has outperformed the market over the past 15 years by 12.92% on an annualized b

4E Therapeutics, Inc. ("4E"), an Austin-based neuroscience company developing next-generatio